Pathologic Stage IIIC Cutaneous Melanoma AJCC v8

specific

Stage IIB includes: (T3b, N0, M0); (T4a, N0, M0). T3b: Tumor measuring more than 2.0 and equal to or less than 4.0 mm in thickness. Ulceration status: With ulceration. T4a: Tumor measuring more than 4.0 mm in thickness. Ulceration status: Without ulceration. N0: No regional lymph node metastasis detected. Presence of in-transit, satellite, and/or microsatellite metastases: No. M0: No evidence of distant metastasis. LDH level is not applicable. (AJCC 8th ed.)

Centers

Active Trials

—

Cancer Funding

Top Centers for Pathologic Stage IIIC Cutaneous Melanoma AJCC v8(25)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	University of Illinois Cancer CenterChicago, IL High-Volume Research Center	High-Volume Research Center	2	—	73.6
2	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program	Active Research Program	1	—	54.7
3	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	54.7
4	UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	54.7
5	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive Active Research Program	Active Research Program	1	—	54.7
6	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program	Active Research Program	1	—	54.7
7	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	54.7
8	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	54.7
9	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	1	—	54.7
10	Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program	Active Research Program	1	—	54.7
11	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program	Active Research Program	1	—	54.7
12	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program	Active Research Program	1	—	54.7
13	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical Active Research Program	Active Research Program	1	—	54.7
14	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program	Active Research Program	1	—	54.7
15	Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program	Active Research Program	1	—	54.7
16	VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program	Active Research Program	1	—	54.7
17	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	1	—	54.7
18	Boston University Cancer CenterBoston, MA Active Research Program	Active Research Program	1	—	54.7
19	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	1	—	54.7
20	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	1	—	54.7
21	The University of Vermont Cancer CenterBurlington, VT Active Research Program	Active Research Program	1	—	54.7
22	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive		—	—	33.1
23	University of Wisconsin Carbone Cancer CenterMadison, WI NCI Comprehensive		—	—	33.1
24	Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive		—	—	33.1
25	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL		—	—	33.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →